Thermo Fisher Scientific Inc (TMO) Shares Bought by Honeywell International Inc.
Honeywell International Inc. grew its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 34.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 194,900 shares of the medical research company’s stock after buying an additional 50,100 shares during the period. Thermo Fisher Scientific comprises 1.3% of Honeywell International Inc.’s portfolio, making the stock its 21st largest position. Honeywell International Inc.’s holdings in Thermo Fisher Scientific were worth $36,875,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in TMO. MAI Capital Management lifted its holdings in Thermo Fisher Scientific by 72.5% during the 1st quarter. MAI Capital Management now owns 3,287 shares of the medical research company’s stock worth $505,000 after buying an additional 1,381 shares during the last quarter. Covington Investment Advisors Inc. raised its position in shares of Thermo Fisher Scientific by 3.4% during the 1st quarter. Covington Investment Advisors Inc. now owns 14,158 shares of the medical research company’s stock worth $2,175,000 after purchasing an additional 460 shares during the period. BB&T Securities LLC raised its position in shares of Thermo Fisher Scientific by 4.4% during the 1st quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock worth $13,798,000 after purchasing an additional 3,819 shares during the period. Municipal Employees Retirement System of Michigan raised its position in shares of Thermo Fisher Scientific by 1.0% during the 1st quarter. Municipal Employees Retirement System of Michigan now owns 12,750 shares of the medical research company’s stock worth $1,958,000 after purchasing an additional 130 shares during the period. Finally, ZWJ Investment Counsel Inc. acquired a new stake in shares of Thermo Fisher Scientific during the 1st quarter worth approximately $7,231,000. 85.32% of the stock is currently owned by institutional investors.
Shares of Thermo Fisher Scientific Inc (NYSE TMO) opened at $190.17 on Monday. Thermo Fisher Scientific Inc has a 1 year low of $139.07 and a 1 year high of $201.20. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81. The company has a market capitalization of $76,257.29, a P/E ratio of 20.90, a P/E/G ratio of 1.74 and a beta of 1.08.
Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period last year, the firm earned $2.03 EPS. The firm’s revenue was up 13.9% compared to the same quarter last year. equities analysts anticipate that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is currently 10.19%.
In other Thermo Fisher Scientific news, VP Seth H. Hoogasian sold 4,140 shares of the stock in a transaction on Monday, August 28th. The stock was sold at an average price of $177.80, for a total transaction of $736,092.00. Following the completion of the transaction, the vice president now directly owns 25,518 shares of the company’s stock, valued at approximately $4,537,100.40. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the transaction, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 60,420 shares of company stock valued at $11,308,477. 0.49% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: “Thermo Fisher Scientific Inc (TMO) Shares Bought by Honeywell International Inc.” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.thecerbatgem.com/2017/11/20/thermo-fisher-scientific-inc-tmo-shares-bought-by-honeywell-international-inc.html.
A number of analysts have recently weighed in on TMO shares. Cowen and Company reiterated an “outperform” rating and set a $220.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Leerink Swann increased their price target on Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research report on Monday, October 9th. Zacks Investment Research cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, October 30th. Goldman Sachs Group, Inc. (The) started coverage on Thermo Fisher Scientific in a research report on Tuesday, September 26th. They set a “buy” rating and a $225.00 price target on the stock. Finally, Deutsche Bank AG set a $226.00 price target on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. One analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus target price of $205.71.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).
Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.